STOCK TITAN

Neurogene: RTW reports 9.3% stake including warrants

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Neurogene Inc. (NGNE) shares are reported as beneficially owned by RTW Investments, LP and Roderick Wong, M.D., RTW’s Managing Partner and Chief Investment Officer. They report shared voting and dispositive power over 1,897,463 shares, or 9.3% of the class. The shares are held directly by RTW Funds, which RTW advises. The reported amount assumes exercise of warrants to purchase 385,007 shares; the percentage calculation uses 20,011,382 shares outstanding as of August 7, 2026. RTW Master Fund Ltd. has the right to receive or direct dividends or sale proceeds from more than 5% of the shares. The reported positions do not constitute an admission by either person of beneficial ownership for Section 13 purposes.

Reported beneficial ownership 1,897,463 shares Shared voting and dispositive power reported by RTW Investments, LP and Roderick Wong, M.D.; assumes exercise of warrants to purchase 385,007 shares
Percentage of class 9.3% Reported by both reporting persons; calculation assumes exercise of warrants and uses 20,011,382 shares outstanding as of August 7, 2026
Warrants 385,007 shares Shares purchasable upon exercise; included in the reported ownership calculation
Shares outstanding 20,011,382 shares As of August 7, 2026
beneficially owned regulatory
"Amount beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power regulatory
"Shared Voting Power 1,897,463.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 1,897,463.00"
Warrants financial
"exercise of Warrants held by the Reporting Persons"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NGNE shares did RTW Investments and Roderick Wong report?

RTW Investments, LP and Roderick Wong, M.D., reported shared beneficial ownership of 1,897,463 Neurogene common shares, with shared voting and dispositive power. The reported amount assumes exercise of warrants to purchase 385,007 shares.

What percentage of NGNE did RTW Investments and Roderick Wong report owning?

They each reported 9.3% of the class. The calculation assumes exercise of warrants to purchase 385,007 shares and is based on 20,011,382 shares outstanding as of August 7, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





64135M105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RTW Investments, LP
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D., Managing Partner
Date:11/16/2026
Roderick Wong
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D.
Date:11/16/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on November 14, 2024).

Keep reading